Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
News
(27)
SEC filing
(20)
Asset
(17)
Filter by content year
(-)
2019
(64)
Filter by form group
Filter by category
Filter by category
Search
SEC Filings
Form EFFECT
SEC Filings
Form FWP
News
BioNTech kündigt weitere Schritte für geplanten Börsengang an
News
BioNTech Announces Commencement of Initial Public Offering
SEC Filings
Form 424B4
Asset
BioNTech gibt Platzierungspreis im Zusammenhang mit Nasdaq Börsengang bekannt
Pressemitteilung auf Deutsch - PDF
333 KB
News
BioNTech veröffentlicht am 14. November 2019 Ergebnisse des dritten Quartals und Informationen zum operativen Fortschritt
News
BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019
Asset
Q3 2019 Financial Report
Q3 2019 Financial Report
329.1 KB
Asset
Finanzbericht 3. Quartal 2019
Biontech Third Quarter 2019 Financial Results (German)
347.3 KB
Pagination
Previous page
‹‹
Page 2
Next page
››